Looking for the latest updates on Acetaminophen Procurement? Explore insightful news and updates for 2025 from Bid Detail. Find essential information to make informed decisions.
Recro Pharma (NASDAQ:REPH) received a buy investment rating Monday from Janney Montgomery Scott, which initiated coverage of the pharmaceutical company’s stock with a price target of $21 per share. Th ......
